We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+7.01%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.7B
AUM Growth
+$679M
(+6.2%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
1,328
New
71
Increased
347
Reduced
587
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$54.8M |
| 2 |
Procter & Gamble
PG
|
+$48.9M |
| 3 |
Applied Materials
AMAT
|
+$39.4M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$38M |
| 5 |
Qualcomm
QCOM
|
+$36.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$41.2M |
| 2 |
Gilead Sciences
GILD
|
+$37M |
| 3 |
AbbVie
ABBV
|
+$35.6M |
| 4 |
Exelon
EXC
|
+$33.2M |
| 5 |
Johnson & Johnson
JNJ
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.91% |
| 2 | Financials | 17.7% |
| 3 | Healthcare | 14.21% |
| 4 | Industrials | 10.49% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$441B
| $70.1M | 0.6% |
1,517,598
-50,662
| -3% | -$2.21M |
|
27
Texas Instruments
TXN
$256B
| $69.8M | 0.6% |
668,537
+149,885
| +29% | +$14.6M |
|
28
General Motors
GM
$82.3B
| $68.4M | 0.58% |
1,667,916
+159,122
| +11% | +$6.9M |
|
|
29
Applied Materials
AMAT
$381B
| $67M | 0.57% |
1,310,733
+728,094
| +125% | +$39.4M |
|
30
MetLife
MET
$62.5B
| $66M | 0.56% |
1,306,279
-70,404
| -5% | -$3.71M |
|
31
Honeywell
HON
$78.4B
| $64.1M | 0.55% |
462,978
-24,992
| -5% | -$3.35M |
|
32
Bread Financial
BFH
$4.3B
| $63.2M | 0.54% |
312,395
+57,096
| +22% | +$10.6M |
|
33
Adobe
ADBE
$101B
| $62.3M | 0.53% |
355,347
+40,828
| +13% | +$7.02M |
|
34
Cisco
CSCO
$461B
| $61.9M | 0.53% |
1,616,760
+664,900
| +70% | +$23.8M |
|
35
Boeing
BA
$175B
| $59.9M | 0.51% |
203,009
-23,749
| -10% | -$6.43M |
|
|
36
Lam Research
LRCX
$339B
| $58.3M | 0.5% |
3,167,760
+2,787,370
| +733% | +$54.8M |
|
37
Agilent Technologies
A
$39.6B
| $58M | 0.5% |
866,300
+55,394
| +7% | +$3.74M |
|
38
Mondelez International
MDLZ
$79.8B
| $56.3M | 0.48% |
1,314,799
+253,979
| +24% | +$10.7M |
|
39
PayPal
PYPL
$51.6B
| $56.3M | 0.48% |
764,075
-39,912
| -5% | -$2.89M |
|
40
Thermo Fisher Scientific
TMO
$214B
| $56.1M | 0.48% |
295,608
+145,687
| +97% | +$27.9M |
|
41
Valero Energy
VLO
$89B
| $55.3M | 0.47% |
601,504
+243,450
| +68% | +$20.1M |
|
42
Abbott
ABT
$187B
| $54.8M | 0.47% |
959,861
-283,691
| -23% | -$15.7M |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $54.4M | 0.46% |
332,486
+31,705
| +11% | +$5.69M |
|
44
Danaher
DHR
$141B
| $53.6M | 0.46% |
651,291
-163,154
| -20% | -$13.3M |
|
45
ConocoPhillips
COP
$139B
| $53.1M | 0.45% |
967,115
+88,990
| +10% | +$4.58M |
|
46
EOG Resources
EOG
$74.6B
| $52.7M | 0.45% |
488,602
-66,029
| -12% | -$6.65M |
|
|
AET
47
DELISTED
Aetna Inc
AET
| $52.7M | 0.45% |
292,002
-105,348
| -27% | -$18.1M |
|
48
Medtronic
MDT
$111B
| $51.9M | 0.44% |
642,639
-168,172
| -21% | -$13.5M |
|
49
UnitedHealth
UNH
$388B
| $51.3M | 0.44% |
232,476
-92,098
| -28% | -$19.5M |
|
|
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
| $50.6M | 0.43% |
696,854
+539,258
| +342% | +$38M |
|
Similar funds
HF
KBC Group's Q4 2017 Portfolio in Review
As of Q4 2017, KBC Group held 1,328 positions worth $11.7B, up 6.2% from $11B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group's Q4 2017 filing shows 71 new, 347 increased, 587 reduced and 69 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M. The largest sale was Celgene Corp, an estimated $41.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- KBC Group's largest Q4 2017 buy was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M.
- KBC Group added most to Lam Research in Q4 2017, an estimated $54.8M increase.
- KBC Group's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $41.2M.
- KBC Group fully exited Gulfport Energy Corp. in Q4 2017, selling an estimated $2.72M.
- KBC Group's ten largest holdings make up 15% of its $11.7B portfolio in Q4 2017.
- KBC Group opened 71 new positions and closed 69 in Q4 2017.
- KBC Group's portfolio value rose 6.2% quarter-over-quarter to $11.7B.
Based on KBC Group's 13F filing for Q4 2017, filed 7 Feb 2018.